• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate Plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    5/10/24 4:30:31 PM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email
    false 0001764046 00-0000000 0001764046 2024-05-07 2024-05-07 0001764046 us-gaap:CommonStockMember 2024-05-07 2024-05-07 0001764046 us-gaap:SeriesAPreferredStockMember 2024-05-07 2024-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of report (date of earliest event reported): May 10, 2024 (May 7, 2024)

     

    CLARIVATE PLC 

    (Exact name of registrant as specified in its charter)

     

    Jersey, Channel Islands

    (State or other jurisdiction of incorporation or organization)

     

    001-38911

    (Commission File Number) 

     

    N/A

    (I.R.S. Employer Identification No.)

     

    70 St. Mary Axe

    London EC3A 8BE
    United Kingdom

     

    (Address of Principal Executive Offices)

     

    (44) 207-433-4000

    Registrant's telephone number, including area code

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Ordinary shares CLVT New York Stock Exchange
    5.25% Series A Mandatory Convertible Preferred Shares, no par value CLVT PR A New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.07.Submission of Matters to a Vote of Security Holders

     

    On May 7, 2024, Clarivate Plc (“Clarivate” or the “Company”) held its 2024 Annual General Meeting of Shareholders.

     

    At that meeting, the shareholders considered and acted upon three proposals pursuant to the Notice of Annual General Meeting of Shareholders and as described in more detail in the Company’s definitive proxy statement dated March 25, 2024 (the "Proxy Statement").

     

    Of 668,143,386 ordinary shares outstanding and entitled to vote as of March 8, 2024 (the “Record Date”), the holders of 605,939,435 ordinary shares were present at the meeting either in person or by proxy, constituting quorum.

     

    All proposals on the agenda were approved by the shareholders.

     

    Below are the final voting results. In tabulating the voting results, only FOR or AGAINST votes are counted. Broker non-votes and abstentions are counted only for purposes of determining whether a quorum is present.

     

    Proposal 1: Election of Directors

     

    Shareholders elected the individuals named below to serve as directors of the Company, with their terms expiring at the Company’s 2025 Annual General Meeting or until their successor is duly elected and qualified. Election of each director required approval by a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    Nominee   For   Against   Abstain   Broker Non-Votes
    Andrew Snyder   567,369,521   20,239,925   34,441   18,295,548
    Jonathan Gear   585,640,184   1,970,430   33,273   18,295,548
    Valeria Alberola   552,696,253   34,882,276   65,358   18,295,548
    Michael Angelakis   582,368,014   5,223,664   52,209   18,295,548
    Jane Okun Bomba   584,555,950   3,047,888   40,049   18,295,548
    Usama N. Cortas   583,025,081   4,569,295   49,511   18,295,548
    Suzanne Heywood   576,841,845   10,754,939   47,103   18,295,548
    Adam T. Levyn   585,606,183   1,995,319   42,385   18,295,548
    Anthony Munk   552,721,820   34,862,190   59,877   18,295,548
    Wendell Pritchett   542,104,109   45,069,213   470,565   18,295,548
    Richard W. Roedel   546,176,223   41,407,129   60,535   18,295,548
    Saurabh Saha   585,950,645   1,631,252   61,990   18,295,548

     

    Proposal 2: Advisory Approval of Executive Compensation

     

    Shareholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    582,480,148   4,825,077   338,662   18,295,548

     

    Proposal 3: Ratification of Appointment of Independent Registered Public Accountants

     

    Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for the fiscal year 2024, on a non-binding and advisory basis. Ratification required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    603,750,294   2,138,490   50,651   -

     

     

     

     

    Item 8.01.Other Events

     

    Date of 2025 Annual General Meeting of Shareholders

     

    Clarivate’s 2025 Annual General Meeting of Shareholders will be held on May 7, 2025. Further details will be provided in the proxy statement for the meeting.

     

    Item 9.01.Financial Statements and Exhibits

     

    (d) Exhibits.

     

    No.   Description
    104   The cover page from this Current Report on Form 8-K formatted in Inline XBRL

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      CLARIVATE PLC
       
    Date: May 10, 2024 By: /s/ Melanie D. Margolin
      Name: Melanie D. Margolin
      Title: Chief Legal Officer

     

     

     

    Get the next $CLVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    1/8/2026$3.60Buy → Neutral
    Goldman
    12/17/2025$3.00Equal-Weight → Underweight
    Morgan Stanley
    9/3/2025Peer Perform
    Wolfe Research
    7/18/2025$4.50Buy → Hold
    Jefferies
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $CLVT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Clarivate Plc

    DEFA14A - CLARIVATE PLC (0001764046) (Filer)

    4/1/26 8:06:00 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form DEF 14A filed by Clarivate Plc

    DEF 14A - CLARIVATE PLC (0001764046) (Filer)

    4/1/26 7:56:11 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Plc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    3/26/26 4:13:46 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clarivate downgraded by Goldman with a new price target

    Goldman downgraded Clarivate from Buy to Neutral and set a new price target of $3.60

    1/8/26 8:37:08 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Clarivate from Equal-Weight to Underweight and set a new price target of $3.00

    12/17/25 8:52:26 AM ET
    $CLVT
    EDP Services
    Technology

    Wolfe Research initiated coverage on Clarivate

    Wolfe Research initiated coverage of Clarivate with a rating of Peer Perform

    9/3/25 8:37:02 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cornick Kenneth L.

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:46 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form 4 filed by Bomba Jane L Okun

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:40 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form 4 filed by Snyder Andrew Miles

    4 - CLARIVATE PLC (0001764046) (Issuer)

    4/2/26 5:18:33 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clarivate Reveals the AI50 - the Organizations Leading Artificial Intelligence Invention

    LONDON, March 26, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in high-impact artificial intelligence (AI) inventions. Following our announcement of the Top 100 Global Innovators 2026, this report dives deeper into the AI world, where organizations such as NVIDIA, Micron Technology, Alphabet, Qualcomm or Foxconn are creating foundational capability in AI, translating AI into complex systems, and scaling into p

    3/26/26 4:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude

    Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflowsLONDON, March 10, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate's proprietary regulatory intelligence with Claude's AI reasoning capabilities. The collaboration gives biopharma, biotech, medtech and clinical research organizations intelligent, context-aware access to authoritative regulatory data within the AI workflows they already use.

    3/10/26 4:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate to Present at the Wolfe Research FinTech Forum on March 10

    LONDON, March 4, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Wolfe Research FinTech Forum, on Tuesday, March 10, 2026 at 10:55 am Eastern Time. The live webcast can be accessed at https://event.summitcast.com/view/6TbwwRgcrsMqMH9MnDuEEt/guest_book?session_id=SKXtYVEftt9CfQ9kjfMcvp and will be available for replay. A replay of the webcast will also be available on https://ir.clarivate.com and will remain ava

    3/4/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cornick Kenneth L. bought $345,000 worth of Ordinary Shares (100,000 units at $3.45) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/13/25 8:51:35 AM ET
    $CLVT
    EDP Services
    Technology

    Director Cornick Kenneth L. bought $2,482,000 worth of Ordinary Shares (725,000 units at $3.42) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 7:20:21 PM ET
    $CLVT
    EDP Services
    Technology

    Director Snyder Andrew Miles bought $4,861,800 worth of Ordinary Shares (1,460,000 units at $3.33) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    11/3/25 5:16:01 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Financials

    Live finance-specific insights

    View All

    Clarivate Reports Fourth Quarter and Full Year 2025 Results

    — Value Creation Plan accelerated organic ACV and drove higher cash flow in 2025 —— Financial outlook for 2026 projects continued momentum —— Provides update on strategic review; Currently engaged in active discussions with interested parties to sell Life Sciences & Healthcare business —LONDON, Feb. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2025. Executive CommentaryMatti Shem Tov, Chief Executive Office

    2/24/26 6:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Impactive Capital Nominates Four Candidates to WEX Board

    Contends Board Level Change is Required to Address Alarming Share Price Underperformance, Culture of Entrenchment and Widening Valuation Gap Versus Its Closest Peer Nominees Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe Each Bring an Owner's Perspective and the Relevant Industry Experience to Strengthen Strategic Oversight, Enhance Capital Allocation and Improve Operational Performance Nominees Have Demonstrated Conviction in WEX's Value Potential and Personally Purchased More Shares Than the Entire Incumbent Board Over the Past Nine Years Impactive Capital, LP, ("Impactive" or "we") together with its affiliates, one of the largest shareholders of WEX Inc. (NYSE:WEX)

    2/9/26 8:00:00 AM ET
    $ADP
    $CLVT
    $CPAY
    Diversified Commercial Services
    Industrials
    EDP Services
    Technology

    Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

    LONDON, Jan. 28, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth quarter and full year 2025 before the market opens on Tuesday, February 24, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, February 24, 2026 to review the results. The webcast is o

    1/28/26 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    View All

    VideoAmp Expands Board with Former Tech and Data Industry Leaders Jonathan Gear and Sari Granat

    Seasoned executives from Clarivate, IHS Markit and Chainalysis join to guide next-phase innovation and scaling at VideoAmp VideoAmp, a leading advertising technology company, today announced the appointment of Jonathan Gear and Sari Granat to its Board of Directors. Gear and Granat bring extensive leadership experience across information services, SaaS, analytics, and global technology, strengthening VideoAmp's mission to modernize measurement and deliver higher fidelity, outcome-based currency for the industry. Jonathan Gear most recently served as Chief Executive Officer of Clarivate (NYSE:CLVT), a global information and analytics company, where he led a strategic repositioning to drive

    12/2/25 9:00:00 AM ET
    $AIZ
    $CLVT
    $INFO
    Property-Casualty Insurers
    Finance
    EDP Services
    Technology

    Clarivate Announces Maroun S. Mourad as President, Intellectual Property

    LONDON, July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025. Maroun most recently served as President of the Claims Solutions division of Verisk Analytics Inc. He succeeds Gordon Samson, who will retire at the end of 2025 after a high-impact career in the IP industry, spending five years as the Chief Operating Officer at CPA Global, before joining the Clarivate executive team, most recently as the President of the IP segment.

    7/30/25 6:01:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

    Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

    4/26/23 7:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Clarivate Plc

    SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

    12/5/24 10:02:09 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13G filed by Clarivate Plc

    SC 13G - CLARIVATE PLC (0001764046) (Subject)

    11/13/24 4:18:30 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

    SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

    3/4/24 9:01:44 AM ET
    $CLVT
    EDP Services
    Technology